TMCnet News
iRhythm Technologies Announces Proposed Public Offering of Common StockSAN FRANCISCO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock. All of the shares in the offering are being offered for sale by iRhythm Technologies. In addition, iRhythm Technologies expects to grant the underwriters a 30-day option to purchase an additional $15,000,000 of shares of its common stock in the offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. J.P. Morgan and Morgan Stanley are serving as joint lead book-running managers for the proposed offering. A registration statement (including a base prospectus) has been filed and a preliminary prospectus supplement relating to these securities will be filed with the U.S. Securities and Exchange Commission (the SEC) for the offering to which this press release relates. The registration statement became effective on September 4, 2019 when filed with the SEC. Before you invest, you should read the preliminary prospectus supplement, the accompanying base prospectus in the registration statement and the other documents iRhythm Technologies has filed with the SEC for more complete information about iRhythm Technologies and this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, copies may be obtained, when available, from: J.P. Morgan Securities LLC, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, via telephone: (866) 803-9204, or via email: [email protected]; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About iRhythm Technologies, Inc. Forward-Looking Statements Investor Relations Contact |